Introduction {#s1}
============

Musculoskeletal conditions are the dominant source of chronic pain worldwide,[@R1] and the basis for the most common pain complaints presented to primary care.[@R2; @R3; @R4] Conditions such as low back pain (LPB) and osteoarthritis (OA) have a significant impact on individuals and healthcare systems.[@R5] Compared with other morbidities, for instance, cancer and heart disease, there remain significant gaps in our understanding of the frequency and management of musculoskeletal (MSK) conditions and their variations between countries. Comparisons between countries would allow further exploration of the pathogenesis of MSK conditions and assessment of differences in healthcare.

Routinely collected electronic healthcare data provide a valuable source of information on trends and variation in the occurrence, determinants, consequences and management of health problems. With falling response rates and under-representation of segments of the population in surveys, healthcare databases may provide the most valid basis for quantifying occurrence of morbidity.[@R6] Yet, comparing estimates on healthcare use even within the same country can be difficult,[@R7] [@R8] and there are further complications in cross-national comparisons.

The first challenge relates to differences in healthcare systems. In England, general practice is the gatekeeper to the health service and the place where the majority of new problems are seen. In other countries, for instance Sweden, direct access to specialty services, such as physiotherapy, is possible. The second challenge relates to the characteristics of data collected in healthcare databases. There may be differences in the extent of data collected (eg, every contact may be recorded in some systems but not in others), and in training and incentives given to healthcare professionals for morbidity recording. Databases may use different coding systems. In primary care in England, morbidities are generally recorded using Read Codes.[@R9] The Read Code system is a hierarchical system structured into chapters. Codes under Chapter N represent 'Musculoskeletal and Connective Tissue Diseases'. Elsewhere, including Sweden, morbidities are recorded using International Classification of Disease (ICD-10) codes. The ICD-10 is also hierarchical, Chapter 13 (M) representing 'Diseases of the Musculoskeletal System and Connective Tissue'.

Consultation prevalence of some MSK conditions,[@R8] [@R10; @R11; @R12] and MSK symptoms by body region,[@R13; @R14; @R15; @R16] have been presented for localities within nations. However, comparing occurrence of MSK conditions presents further challenges, including obtaining valid and comparable case definitions when use of diagnostic labels, such as OA, often varies between healthcare professionals.[@R17] [@R18] The inflexibility of coding systems also raise challenges. Although diagnoses have a clear coding system, symptoms such as joint pain and back pain may be spread across several chapters including the MSK, symptoms and injury chapters.[@R13]

The objectives were, first, to assess the feasibility of comparing the consultation prevalence of MSK conditions between nations with different healthcare and recording systems and, second, to determine the consultation prevalence of specific MSK conditions cross-nationally.

To determine feasibility, we first attempted to harmonise case definitions, data extraction and analysis procedures. Second, prior to analysis, we identified known differences in the healthcare systems and recording practices likely to affect prevalence comparisons. Third, we applied adjustments to the calculation of prevalence where there was a previously established empirical basis for doing so.

Methods {#s2}
=======

Setting {#s2a}
-------

The study was set within an English and a Swedish healthcare database, two countries with different healthcare and coding systems. The Consultations in Primary Care Archive (CiPCA) contains all recorded consultation data by GPs and practice nurses from 13 general practices in North Staffordshire, England.[@R8] [@R19] The practices undergo an annual cycle of assessment, feedback and training in morbidity coding.[@R19] Approximately, 97% of all contacts with a GP have a morbidity code assigned. CiPCA has been shown to give similar annual primary care consultation prevalence figures for MSK conditions, OA, rheumatoid arthritis (RA) and arthralgia as a UK national database.[@R8] In England, over 95% of the population are registered with a general practice, and general practice is the first point of access to the National Health Service for most non-emergency care, and provides continuing care for many chronic diseases. Ethical approval for CiPCA was granted by the North Staffordshire Research Ethics Committee. This study used data from 11 practices which have continuously contributed to CiPCA since 2003. These practices had a total registered population of 94 565 in 2010, and cover a range of areas in terms of deprivation, although generally North Staffordshire is more deprived than England as a whole. Although CiPCA is a primary care database, secondary care information (eg, hospital letters) is also recorded and coded at the discretion of the practices. Recording of secondary care information, therefore, will not be complete and will vary by practice.

In Sweden, all healthcare consultations are recorded in county-specific databases. Skåne is the southernmost county. The Skåne Health Care Register (SHCR) holds details for primary and secondary care for 1 243 329 inhabitants in 2010 (about one-eighth of the Swedish population). In Sweden, all patients are registered to a general practice. However, a patient does not need to attend primary care before seeing a specialist, although this is the most common process. Each consultation generates data entries (eg, diagnostic code) that are transferred to the SHCR and which constitute the basis for reimbursement to the healthcare providers. Similar regulations apply to both public and private healthcare providers, and both are easily accessed. Studies of RA and spondyloarthritis have suggested high validity of diagnostic coding.[@R10] [@R11] Approximately 90% of public primary care consultations and 99% of secondary care consultations have diagnostic codes recorded in the SHCR. However, diagnostic codes recorded by private outpatient and private primary care providers are not yet automatically transferred to the SHCR. Diagnostic codes recorded by professionals other than doctors are not complete and not included in this analysis. Ethical approval for using data from SHCR for research purposes was given by the Research Ethics Committee at Lund University. The Swedish Population Register is the civil registration of vital events (eg, deaths, change of address). This register can be cross-referenced with the SHCR to determine subjects who have died or relocated out of the county.

Morbidities {#s2b}
-----------

Consultation prevalences based on (1) primary care only and (2) both primary and secondary care were determined in each database for any doctor-diagnosed MSK condition, non-specific low back pain, OA, RA, and spondyloarthritis (SpA---as a group, and specifically, ankylosing spondylitis (AS), and psoriatic arthritis). In addition, as OA may be recorded as joint pain in the older population, the prevalence of OA or joint pain was derived for the population aged 45 years and over.

Feasibility criteria {#s2c}
--------------------

Assessment of the feasibility of comparing prevalence between England and Sweden was based on two criteria. First, whether the methodology for deriving consultation prevalence could be standardised between the two nations. Feasibility would not be shown if we were unable to translate any part of the methods between the two nations (eg, standardisation between Read and ICD codes). The second criterion was based on two known characteristics of the healthcare systems and recording practices. Direct access to physiotherapy for back pain in Sweden (ie, without referral from a GP) is common but not routinely recorded with a diagnostic code in the SHCR, and there is more complete recording of secondary care in the Swedish than English database. Therefore, the expectation was that there would be a difference between the nations in consultation prevalence of low back pain (higher in England) and of inflammatory disorders when based on primary and secondary care data (higher in Sweden). There should be less marked differences in the prevalence of OA and in primary care prevalence of inflammatory disorders, given evidence that population prevalence of MSK pain (eg, chronic widespread pain) is similar in UK and Sweden.[@R20] [@R21]

Morbidity definitions {#s2d}
---------------------

Based on previous work in Sweden, [@R10] [@R11] [@R14] [@R22] together with discussions within the research team, ICD-10 codes for the morbidities were identified. Low back pain included codes with the terms 'backache' and 'back pain' with no region (lower or upper) stated, as it is presumed the majority of these will be related to low back pain. Primary care consultation prevalence of recorded upper back pain has previously been shown to be only 5% of that of lower back pain in the English database.[@R13] The selected ICD-10 codes were then matched to Read Codes by KJ using a strict mapping of ICD-10 codes to Read Codes. Two research GPs in England also independently matched Read Codes and their linked terms to the definitions for the ICD-10 codes. The GPs did not use the mapping list used by KJ. Disagreements between KJ and the GPs were resolved by consensus.

There were two exceptions to the above process. Codes for joint pain relating to knee, hip, hand/wrist and foot/ankle were previously derived for a separate study in England by a GP research fellow (JE) through (1) a consensus exercise with other GPs and (2) assessment of their recorded use in CiPCA. The identified Read Codes were mapped back to ICD-10 codes by AJ with discussions among the research team. A MSK condition was defined as any recorded code within the Musculoskeletal and Connective Tissue Diseases Chapters of the Read Code (England) or ICD-10 (Sweden) systems. See online supplementary table S1 for the definitions used.

Analysis {#s2e}
--------

Primary care consultation prevalence was defined as the number of patients consulting primary care at least once with the relevant morbidity code recorded during the time period of interest per 10 000 registered population.

Two time periods were used: The calendar year 2010 was used to determine annual consultation prevalence with the registered population at 31 December 2010 as the denominator population.The time period 1 January 2004 to 31 December 2010 was used to determine the 7-year period consultation prevalence in the denominator population. Both numerator and denominator were restricted to those who were registered at 31 December 2010. Hence, for chronic diseases this gives an estimate of the point prevalence of the morbidity in the current registered population.

Patients were only counted once for each condition, hence, repeat consultations for the same condition in the time period of interest were ignored. If a patient consulted for more than one of the conditions during that time period, they were included in the numerator for both. Diagnostic codes from private care are not automatically transferred to the SHCR. The proportion of contacts with private primary care doctors is approximately 30% of all primary care doctor visits and, therefore, the denominator for the Sweden database was reduced by 30%.[@R14] This correction was not designed to address the separate issue of direct access to physiotherapy for low back pain in the Swedish healthcare system, which remained a potential source of bias in the two-country comparison.

The analyses were repeated including secondary care data to derive combined primary and secondary care consultation prevalence, on the assumption that some patients may be diagnosed or only consult in secondary care as is particularly likely in Sweden. Since private specialised care is less common than for primary care, the denominator for Sweden for all healthcare was reduced by 15%. The derivation and empirical justification of these adjustments have been presented in earlier papers.[@R10] [@R11] [@R14]

Total and age-gender specific consultation prevalences for each database were determined. There was no restriction by age except for the combined analysis of OA and joint pain which was calculated for ages 45 years and over. Age was defined as age at 31 December 2010. The age and gender structure of the registered populations for the two databases were similar, hence unstandardised results are presented ([table 1](#ANNRHEUMDIS2012202634TB1){ref-type="table"}).

###### 

Registered populations at 31 December 2010

  Age       CiPCA; n (%)   SHCR; n (%)
  --------- -------------- -------------
  Women                    
   0--14    7427 (8)       100927 (8)
   15--24   5511 (6)       81931 (7)
   25--44   12283 (13)     163828 (13)
   45--64   12786 (14)     154292 (12)
   65--74   4999 (5)       62552 (5)
   75+      5061 (5)       63804 (5)
  Men                      
   0--14    7738 (8)       106707 (9)
   15--24   5613 (6)       83271 (7)
   25--44   12553 (13)     169078 (14)
   45--64   12761 (13)     155032 (12)
   65--74   4603 (5)       59787 (5)
   75+      3230 (3)       42120 (3)
  Total     94565          1243329

CiPCA, Consultations in Primary Care Archive; SHCR, Skåne Health Care Register.

Results {#s3}
=======

Annual consultation prevalence {#s3a}
------------------------------

There were 2143 persons per 10 000 in the English database who had a record of consulting primary or secondary care at least once in the year for a MSK condition. The corresponding figure for Sweden was 1610/10 000 ([table 2](#ANNRHEUMDIS2012202634TB2){ref-type="table"}). This overall difference between England and Sweden was apparent predominantly in the different prevalences for low back pain (587 vs 294/10 000). By contrast, RA, SpA and psoriatic arthritis had higher prevalences in the Swedish database, although OA (211 vs 269/10 000) and AS (5 vs 6/10 000) prevalence figures were similar between the two nations.

###### 

Annual consultation prevalence (95% CI) per 10 000 registered population in 2010 (all ages)

                               North Staffordshire, England   Skåne County, Sweden
  ---------------------------- ------------------------------ ----------------------
  Primary and secondary care                                  
   Musculoskeletal (all)       2143 (2114 to 2173)            1610 (1603 to 1617)
   Low back pain               587 (572 to 603)               294 (290 to 297)
   Rheumatoid arthritis        40 (36 to 44)                  59 (58 to 61)
   Spondyloarthritis\*         13 (11 to 16)                  30 (29 to 31)
   Ankylosing spondylitis      5 (3 to 6)                     6 (5 to 6)
   Psoriatic arthritis         8 (6 to 10)                    16 (15 to 17)
   Osteoarthritis              211 (202 to 220)               269 (266 to 272)
  Primary care only                                           
   Musculoskeletal (all)       1967 (1939 to 1995)            1354 (1347 to 1361)
   Low back pain               543 (529 to 558)               290 (286 to 293)
   Rheumatoid arthritis        25 (22 to 28)                  26 (25 to 28)
   Spondyloarthritis\*         8 (7 to 10)                    8 (8 to 9)
   Ankylosing spondylitis      3 (2 to 4)                     0.2 (0.1 to 0.3)
   Psoriatic arthritis         5 (3 to 6)                     3 (3 to 4)
   Osteoarthritis              176 (168 to 185)               196 (193 to 199)

\*Ankylosing spondylitis, psoriatic arthritis, arthropathy in ulcerative colitis, arthropathy in Crohn\'s disease.

When the analysis was restricted to primary care consultations only, the absolute difference in prevalence of MSK consultation was little changed (1967/10 000 England vs 1354/10 000 Sweden), and was again mainly apparent in consultations for low back pain. OA (176 vs 196/10 000), RA (25 vs 26/10 000), SpA (both 8/10 000) and psoriatic arthritis (5 vs 3/10 000) primary care consultation prevalences were similar between the two countries. AS was rarely recorded in Swedish primary care.

Seven-year period consultation prevalence {#s3b}
-----------------------------------------

Similar cross-national patterns to the annual consultation prevalence figures were observed when assessing 7-year period consultation prevalence ([table 3](#ANNRHEUMDIS2012202634TB3){ref-type="table"}). These figures suggest around 700/10 000 received a diagnosis of OA over the 7-year period, between 57 (England) and 90 (Sweden) per 10 000 received a diagnosis of RA, and 10--13/10 000 received a diagnosis of AS.

###### 

Seven-year period consultation prevalence of musculoskeletal conditions\* (95% CI) per 10 000 registered population (all ages)

                               North Staffordshire, England   Skåne County, Sweden
  ---------------------------- ------------------------------ ----------------------
  Primary and secondary care                                  
   Musculoskeletal (all)       5055 (5010 to 5101)            4278 (4269 to 4288)
   Low back pain               2113 (2083 to 2142)            1093 (1087 to 1099)
   Rheumatoid arthritis        57 (52 to 62)                  90 (89 to 92)
   Spondyloarthritis†          28 (25 to 31)                  62 (60 to 63)
   Ankylosing spondylitis      10 (8 to 12)                   13 (13 to 14)
   Psoriatic arthritis         13 (11 to 15)                  30 (29 to 31)
   Osteoarthritis              651 (635 to 667)               733 (728 to 738)
  Primary care only                                           
   Musculoskeletal (all)       4914 (4869 to 4959)            3895 (3885 to 3905)
   Low back pain               2053 (2024 to 2082)            1077 (1070 to 1083)
   Rheumatoid arthritis        48 (43 to 52)                  52 (51 to 54)
   Spondyloarthritis†          23 (20 to 27)                  21 (20 to 22)
   Ankylosing spondylitis      8 (6 to 10)                    0.4 (0.3 to 0.6)
   Psoriatic arthritis         10 (8 to 13)                   8 (7 to 8)
   Osteoarthritis              586 (571 to 602)               493 (489 to 498)

\*Any record of condition between 2004 and 2010.

†Ankylosing spondylitis, psoriatic arthritis, arthropathy in ulcerative colitis, arthropathy in Crohn\'s disease.

OA and joint pain {#s3c}
-----------------

The consultation prevalence of diagnosed OA in those aged 45 years and over was reasonably consistent between England and Sweden at around 500/10 000 (annual) and 1400--1500/10 000 (7-year period consultation prevalence) ([table 4](#ANNRHEUMDIS2012202634TB4){ref-type="table"}). Including joint pain codes with OA increased these figures to around 1100/10 000 (annual) and 3400/10 000 (7-year period consultation prevalence) although recorded joint pain prevalence was slightly higher for England.

###### 

Consultation prevalence of osteoarthritis and joint pain\* (95% CI) per 10 000 registered population aged 45 years and over

                                               North Staffordshire, England   Skåne County, Sweden
  -------------------------------------------- ------------------------------ ----------------------
  Annual consultation prevalence 2010                                         
   Primary and secondary care                                                 
    Osteoarthritis                             447 (428 to 468)               578 (571 to 585)
    Joint pain                                 875 (847 to 903)               631 (624 to 638)
    Osteoarthritis or joint pain               1192 (1160 to 1225)            1094 (1085 to 1103)
   Primary care only                                                          
    Osteoarthritis                             375 (357 to 393)               443 (436 to 449)
    Joint pain                                 794 (768 to 821)               603 (596 to 610)
    Osteoarthritis or joint pain               1074 (1044 to 1106)            967 (958 to 977)
  Seven-year period consultation prevalence†                                  
   Primary and secondary care                                                 
    Osteoarthritis                             1388 (1353 to 1423)            1563 (1553 to 1574)
    Joint pain                                 2942 (2892 to 2994)            2459 (2445 to 2472)
    Osteoarthritis or joint pain               3483 (3428 to 3539)            3346 (3332 to 3360)
   Primary care only                                                          
    Osteoarthritis                             1254 (1221 to 1288)            1111 (1101 to 1121)
    Joint pain                                 2847 (2797 to 2898)            2511 (2498 to 2524)
    Osteoarthritis or joint pain               3363 (3308 to 3418)            3075 (3060 to 3089)

\*People had to be aged 45 years or over when receiving joint pain code.

†Any record of morbidity between 2004 and 2010.

Age-gender patterns {#s3d}
-------------------

Age-gender patterns were generally similar between England and Sweden ([figures 1](#ANNRHEUMDIS2012202634F1){ref-type="fig"} and [2](#ANNRHEUMDIS2012202634F2){ref-type="fig"}). There was a more evident plateau in low back pain prevalence at the older ages in England, while the higher prevalence of RA for women was more marked in Sweden.

![Annual (2010) consultation prevalence of musculoskeletal conditions by age and sex. All care includes primary and secondary care. LBP, low back pain; MSK, musculoskeletal; OA, osteoarthritis; PC, primary care; RA, rheumatoid arthritis; SpA, spondyloarthritis.](annrheumdis-2012-202634f01){#ANNRHEUMDIS2012202634F1}

![Seven year (2004--2010) period consultation prevalence of musculoskeletal conditions by age and sex. (LBP, low back pain; MSK, musculoskeletal; OA, osteoarthritis; PC, primary care; RA, rheumatoid arthritis; SpA, spondyloarthritis).](annrheumdis-2012-202634f02){#ANNRHEUMDIS2012202634F2}

Sensitivity analysis {#s3e}
--------------------

To correct for missing codes from private doctors, we adjusted the denominator for Swedish consultation prevalence by 30% for primary care and 15% when including secondary care. Sensitivity analyses using a 25% or 35% adjustment for primary care changes the annual consultation prevalence figures for RA from 26/10 000 to 25/10 000 and 28/10 000, respectively. For SpA, consultation prevalence remained at 8/10 000 with 25% adjustment and increased to 9/10 000 with 35% adjustment. Estimated low back pain annual consultation prevalence reduced from 290 to 270/10 000 with 25% adjustment, and increased to 312/10 000 with 35% adjustment. For OA, the prevalence changed from 196/10 000 to 183/10 000 and 211/10 000, respectively.

Discussion {#s4}
==========

Comparisons of routine healthcare data between countries and healthcare systems allow opportunities to study causes and differences in management and outcome of morbidities. All databases using routine morbidity coding will incorporate variation by clinicians in diagnostic criteria and in recording of morbidities, potentially leading to variation in recorded prevalence. Between countries, such variations may be exacerbated by differences in coding systems and contrasting components of the healthcare systems which may affect how morbidity data is recorded and collected. There may also be underlying differences in the occurrence of different conditions between countries and in the delivery and effectiveness of healthcare, contributing to observed differences in prevalence figures.

However, it appears feasible to compare consultation prevalence between nations by using a rigorous approach to data organisation and extraction. The approach we used included the matching of Read Codes to ICD-10 codes through structured consensus processes of researchers and clinicians, prior to extraction of consultations, suggesting the two coding systems can be mapped to allow comparisons between international healthcare systems. We observed some consistency in consultation prevalence of MSK conditions between English and Swedish databases despite their dissimilar healthcare systems and recording practices. The contrasts we observed were expected and may be partially explained by two known differences. First, direct access to some primary care in Sweden, for instance, physiotherapy for back pain, is not routinely recorded in the SHCR. Second is the direct transfer of secondary care data to the SHCR in Sweden.

Consultation prevalence of low back pain in Sweden was only half of that found in England and may be a result of patients in Sweden having direct access to physiotherapists whose diagnostic codes are not comprehensively recorded in the SHCR. Patients who directly access physiotherapy tend to be younger, more educated and more likely to have unspecified symptoms,[@R23] [@R24] and approximately 70% of low back pain patients have their initial contact with a physiotherapist (unpublished data). Differences between the nations in consultation prevalence for inflammatory conditions using both primary and secondary care data may reflect the nature of the conditions in being diagnosed and seen more commonly in secondary care, as suggested by the increased prevalence when secondary care is considered in the SHCR database. Although English general practices, such as those included in CiPCA, do not comprehensively record diagnoses made in secondary care, it might be expected that a person with a diagnosis in secondary care would obtain a record of this at least once over 7 years. However, the combined primary and secondary care figures for England are likely to be an underestimate of consultation prevalence for the inflammatory conditions, and the true prevalence is likely to be closer to the figures derived for Sweden.

One challenge in comparing consultation prevalence figures is in deciding on what constitutes 'similar' prevalence. Consideration of absolute differences may prove the best approach to comparing consultation prevalence. For example, Swedish annual primary and secondary care prevalence of psoriatic arthritis is twice that for England, but the absolute difference is low (eight extra people consulting per 10 000), whereas for a more prevalent condition like low back pain, a similar relative ratio constitutes a larger absolute difference (293 extra people consulting in England per 10 000).

The prevalence figures reflect the burden of MSK conditions with 15--20% of people seeking care for a MSK problem during the course of a year, rising to 50% (5055/10 000 England; 4278/10 000 Sweden) over the course of 7 years. Low back pain and OA are common with a third of older adults consulting for OA or joint pain over a 7-year period.

The annual primary care consultation prevalence figures for all MSK conditions, OA and RA are similar to the last published figures (for year 2007) from the national Research and Surveillance Centre across England and Wales (all MSK 1692/10 000; OA 188/10 000; RA: 30/10 000).[@R25] The 7 year combined primary and secondary care period consultation prevalence figures for OA are not dissimilar to those identified in British Columbia, Canada, for the period 1994--2001 (approximately 900/10 000), although that study showed that increasing the period from seven to 10 years increased the consultation prevalence of diagnosed OA in the current registered population by about 20%.[@R12] Therefore, the 7-year figures given here may be a slight underestimate of the actual current prevalences of the chronic diseases investigated, although those without a healthcare record for more than 7 years would probably have milder symptoms.

Diagnostic codes from private care are not automatically transferred to the SHCR. Both private and public care in Sweden are easily accessed with the same patient cost. Selection bias between private and public care is possible, but due to the nature of the Swedish healthcare system, unlikely to be substantial. In 2010, 69% of all patients consulting privately were aged 20--69 years, compared with 58% for public care. The consultation prevalence figures for working-age individuals from Sweden may hence be slightly underestimated.

We based our prevalence figures on the underlying diagnosis favoured by the doctor at time of recording. Validation data for RA and SpA from SHCR support high accuracy of the diagnostic coding.[@R10] [@R11] CiPCA covers one area of England but has been shown to give comparable prevalence figures to national databases.[@R8] People registering at the CiPCA practices or moving into Skåne after the start of 2004 will not have a full 7 years of medical record information. This is likely to be a bigger proportion of the registered population of the more local CiPCA database than SHCR. Repeating the 7-year prevalence analysis in CiPCA for just those fully registered between 2004 and 2010 increased consultation prevalence from 651 to 758/10 000 but only increased prevalence of RA by 10% and less for the other conditions. We assumed that a code of backache or back pain, without lower or upper region specified, would most likely refer to low back pain, given the low prevalence of upper back pain.[@R13] However, it is possible that some individuals with only upper back pain may have been included.

Our study suggests that use of a rigorous methodological approach allows feasible comparison between England and Sweden and some consistency in consultation prevalence figures despite differences in healthcare and recording systems. Differences observed will represent contrasts in diagnosis, coding or healthcare referral practice in the two countries, but may also include real variations in prevalence. As deeper understanding is gained about healthcare data in different countries, so these different possibilities can be explored. Further research should, therefore, examine whether consistency can be found between other European and non-European countries.
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